S-1/A

AMENDMENT NO. 1 TO REGISTRATION STATEMENT

Company: Citius Pharmaceuticals, Inc.
Filed: August 6, 2018
Accession Number: 0001213900-18-010251

View Document ↗ View on SEC.gov ↗